ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

Project Expands Group Studies To Community Oncologists.

March 10, 2000